Biphasic autoxidation of tetralin has been carried out
using surface-active tetramethylethylenediamine complexes
of manganese, chromium, and nickel as catalysts, tetralin as the
substrate and organic phase, and dodecyl
sodium sulfate as emulsifier. Advantages of the biphasic reaction
over the homogeneous and heterogeneous
counterparts include avoidance of the use of a troublesome solvent,
ease of catalyst recovery and substrate
recycle, and attainment of high reactivity, selectivity, and
reproducibility under mild reaction conditions
(T
∼ 60 °C, P ∼ 1 atm). The main reaction products
are α-tetralone and α-tetralol. The selectivity for
the
former decreases from 95% with the chromium complex to 90% with the
nickel complex and 60% with the
manganese complex, and the activity varies in a reverse order. The
biphasic reaction stops at a bulk tetralin
conversion of 35% due to the buildup of inhibitive, higher oxidation
products. Similar product inhibition has
been reported in one-liquid-phase systems. The biphasic scheme,
however, permits a more convenient recovery
and recycle of the catalyst and unreacted substrate. The reaction
order with respect to oxygen decreases
from 1.0 to 0 above an oxygen pressure of 0.15 atm. The reaction
order with respect to catalyst decreases
from 2.0 or 1.4 to 1.0 and then 0 with increasing metal concentration.
Manganese switches role from catalyst
to inhibitor above a threshold metal concentration, as indicated by a
lengthening of the induction period of
the reaction. A generalized reaction mechanism is proposed which
yields model results in good agreement
with the experimental findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.